Pharmacogenetic testing, which is used to classify how patients with major depressive disorder (MDD) metabolize medications, reduces adverse drug-gene interactions, new research shows. In a randomized ...

New research reveals that tirzepatide and semaglutide both offer strong, early heart-protective effects. A major new ...

A tailored approach of vitamin D3 supplementation in patients who have suffered a heart attack significantly reduces their ...